Aradigm Corporation
3929 Point Eden Way
Hayward
California
94545
United States
Tel: 510-265-9000
Fax: 510-265-0277
Website: http://www.aradigm.com/
213 articles about Aradigm Corporation
-
Aradigm Corporation Applies To Transfer Listing To Nasdaq Capital Market
4/25/2006
-
Aradigm Corporation First Quarter 2006 Earnings And Conference Call Notification
4/24/2006
-
Aradigm Corporation Receives Nasdaq Notice Of Non-Compliance With Nasdaq Marketplace Rules
4/3/2006
-
Aradigm Corporation And APT Pharmaceutical LLC Initiate Phase 2 Clinical Program Of Novel Treatment For Asthma
3/23/2006
-
Aradigm Corporation Reports Novo Nordisk A/S To Initiate Additional Phase 3 Clinical Trials Of AERx Diabetes Management System
3/7/2006
-
Aradigm Corporation Announces Fourth Quarter And Year End 2005 Financial Results
2/23/2006
-
Aradigm Corporation Fourth Quarter And Full Year 2005 Earnings And Conference Call Notification
2/15/2006
-
Aradigm Corporation Files Request For Orphan Drug Designation For Inhaled Liposomal Ciprofloxacin For Cystic Fibrosis
1/5/2006
-
Aradigm Corporation Completes Manufacture Of Intraject Sumatriptan Pivotal Stability Lots
12/21/2005
-
Aradigm Corporation Receives Nasdaq Notice Of Bid Price Rule Non-Compliance
12/1/2005
-
Aradigm Corporation Reports Third Quarter 2005 Financial Results
11/2/2005
-
Aradigm Corporation To Webcast Presentation At Rodman And Renshaw 7th Annual Techvest Healthcare Conference
10/27/2005
-
Aradigm Corporation And United Therapeutics Corporation Sign Development and Commercialization Agreement Targeting Pulmonary Hypertension
10/24/2005